Table 3. Association of different clinical variables with MACEs, bleeding events and death during follow-up. Statistically significant values appear in bold.

	MACEs		Bleeding events		Deaths
	Univariate	Multivariate	Univariate	Multivariate	Univariate	Multivariate
	HR (95% CI) p	HR (95% CI) p	HR (95% CI) p	HR (95% CI) p	HR (95% CI) p	HR (95% CI) p
Catheterism (non-performed)	2.97 (1.89-4.66) p<0.001	16.16 (6.06-43.12) p<0.0011	1.06 (0.59-1.90) p=0.850		3.34 (2.07-5.38) p<0.001	3.32 (0.39-28.29) p=0.272
LMCA involvement	2.63 (1.36-5.07) p=0.004	2.09 (1.05-4.15) p=0.036	1.21 (0.52-2.83) p=0.655		2.15 (1.02-4.53) p=0.044	1.63 (0.46-5.75) p=0.445
Revascularization (non-performed)	2.09 (1.33-3.28) p=0.001	1.82 (0.93-3.54) p=0.080	1.50 (0.90-2.48) p=0.119	1.80 (0.95-3,38) p=0.070	2.45 (1.49-3.93) p<0.001	13.05 (4.00-42.49) p<0.001
Significant lessions in CA	0.19 (0.03-1.37) p=0.099	6.82 (0.88-52.83) p=0.066	6.47 (0.89-46.74) p=0.164		4,40 (0.60-32.05) p=0.164
Non-pharmacological stents	0.71 (0.34-1.49) p=0.364		1.16 (0.60-2.25) p=0.655		2.47 (1.15-5.34) p=0.021	1.87 (0.84-4.19) p=0.126
ASA at discharge	1.07 (0.39-2.92) p=0.901		2.19 (0.95-5.06) p=0.067	2.19 (0.68-7.10) p=0.192	1.25 (0.46-3.44) p=0.661
Clopidogrel at discharge	1.15 (0.73-1.83) p=0.544		2.68 (0.97-7.41) p=0.049	2.92 (1.05-8.14) p=0.041	2.77 (1.00-7.66) p=0.049	1.99 (0.56-6.99) p=0.286
Anticoagulants at discharge	1.28 (0.72-2.29) p=0.401		1.45 (0.86-2.46) p=0.166		1.32 (0.71-2.45) p=0.378
β-blockers at discharge	1.93 (1.21-3.07) p=0.006	1.47 (0.74-2.92) p=0.269	1.42 (0.85-2.40) p=0.183		1.54 (0.92-2.57) p=0.099	1.54 (0.61-3.88) p=0.358
ACEI and ARBs at discharge	0.93 (0.54-1.61) p=0.799		1.10 (0.63-1.93) p=0.730		1.40 (0.83-2.37) p=0.213
Calcium antagonists at discharge	1.37 (0.81-2.29) p=0.238		1.66 (0.83-3.35) p=0.155		1.52 (0.89-2.60) p=0.126	0.98 (0.32-2.93) p=0.964
Statins at discharge	0.85 (0.31-2.33) p=0.756		1.25 (0.51-3.12) p=0.626		0.97 (0.35-2.66) p=0.950